Clinical Trial Update: Study of SGB-3908 in Healthy Subjects and Mildly Hypertensive Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial update for SGB-3908 in healthy subjects and individuals with essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• SGB-3908

Snippet

Sponsor: Suzhou Sanegene Bio Inc. | Conditions: Hypertension,Essential | Phase 1 | Status: COMPLETED